Use of a novel cytotoxic HEXIM1 peptide in the directed breast cancer therapy

• Main Authors: Neo, S.H, Lew, Q.J, Koh, S.M, Zheng, L, Bi, X, Chao, S.-H
• Other Authors: MICROBIOLOGY AND IMMUNOLOGY
• Format: Article
• Published: 2020
• Subjects: antineoplastic agent; caspase; cell penetrating peptide; hexamethylene bisacetamide inducible protein 1 basic region peptide; hybrid protein; nucleophosmin; positive transcription elongation factor b; protein p53; unclassified drug; HEXIM1 protein, human; peptide fragment; RNA binding protein; TP53 protein, human; apoptosis; Article; breast cancer; cell killing; cellular distribution; controlled study; drug cytotoxicity; human; human cell; internalization; membrane depolarization; mitochondrial membrane potential; nucleolus; protein expression; antagonists and inhibitors; Breast Neoplasms; cell proliferation; female; fluorescent antibody technique; genetic transcription; genetics; metabolism; pathology; tumor cell culture; Western blotting; Apoptosis; Blotting, Western; Cell Proliferation; Female; Fluorescent Antibody Technique; Humans; Peptide Fragments; RNA-Binding Proteins; Transcription, Genetic; Tumor Cells, Cultured; Tumor Suppressor Protein p53
• Online Access: https://scholarbank.nus.edu.sg/handle/10635/180864
• Institution: National University of Singapore

10.18632/oncotarget.6794